These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11212172)

  • 1. Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis.
    van Roon JA; Lafeber FP; Bijlsma JW
    Arthritis Rheum; 2001 Jan; 44(1):3-12. PubMed ID: 11212172
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of inflammation and joint destruction in rheumatoid arthritis may require a concerted action of Th2 cytokines.
    van Roon JA; Bijlsma JW; Lafeber FP
    Curr Opin Investig Drugs; 2002 Jul; 3(7):1011-6. PubMed ID: 12186260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy.
    Miossec P
    Arthritis Rheum; 2003 Mar; 48(3):594-601. PubMed ID: 12632409
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of matrix metalloproteinase-3 in joint destruction in rheumatoid arthritis].
    Sugiyama E
    Clin Calcium; 2007 Apr; 17(4):528-34. PubMed ID: 17404481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Joint destruction and its repair in rheumatoid arthritis].
    Kohsaka H
    Clin Calcium; 2009 Mar; 19(3):317-23. PubMed ID: 19252241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis.
    Izmailova ES; Paz N; Alencar H; Chun M; Schopf L; Hepperle M; Lane JH; Harriman G; Xu Y; Ocain T; Weissleder R; Mahmood U; Healy AM; Jaffee B
    Arthritis Rheum; 2007 Jan; 56(1):117-28. PubMed ID: 17195214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced concentrations of interleukin 16 are associated with joint destruction in patients with rheumatoid arthritis.
    Lard LR; Roep BO; Toes RE; Huizinga TW
    J Rheumatol; 2004 Jan; 31(1):35-9. PubMed ID: 14705216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with total alkaloids from Radix Linderae reduces inflammation and joint destruction in type II collagen-induced model for rheumatoid arthritis.
    Wang C; Dai Y; Yang J; Chou G; Wang C; Wang Z
    J Ethnopharmacol; 2007 May; 111(2):322-8. PubMed ID: 17204385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction.
    Mor A; Abramson SB; Pillinger MH
    Clin Immunol; 2005 May; 115(2):118-28. PubMed ID: 15885632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New therapeutic strategy of rheumatoid arthritis to reach the goal of suppression of joint destruction].
    Yamaguchi Y; Yamamoto K
    Clin Calcium; 2007 Apr; 17(4):463-73. PubMed ID: 17404474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of tacrolimus for joint destruction in rheumatoid arthritis].
    Tanaka Y; Suzuki K; Saito K
    Clin Calcium; 2007 Apr; 17(4):593-9. PubMed ID: 17404490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells.
    Gonzalez-Rey E; Chorny A; Varela N; O'Valle F; Delgado M
    Arthritis Rheum; 2007 Feb; 56(2):531-43. PubMed ID: 17265488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between inflammation and joint destruction in early rheumatoid arthritis: a mathematical description.
    Wick MC; Lindblad S; Klareskog L; Van Vollenhoven RF
    Ann Rheum Dis; 2004 Jul; 63(7):848-52. PubMed ID: 15194582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
    Svensson B; Boonen A; Albertsson K; van der Heijde D; Keller C; Hafström I
    Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 10 (IL-10), not IL-4 or interferon-gamma production, correlates with progression of joint destruction in rheumatoid arthritis.
    Verhoef CM; van Roon JA; Vianen ME; Bijlsma JW; Lafeber FP
    J Rheumatol; 2001 Sep; 28(9):1960-6. PubMed ID: 11550960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis.
    Dayer JM
    Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii3-10. PubMed ID: 12817089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does damage cause inflammation? Revisiting the link between joint damage and inflammation.
    Smolen JS; Aletaha D; Steiner G
    Ann Rheum Dis; 2009 Feb; 68(2):159-62. PubMed ID: 19139203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production.
    Abdollahi-Roodsaz S; Joosten LA; Helsen MM; Walgreen B; van Lent PL; van den Bersselaar LA; Koenders MI; van den Berg WB
    Arthritis Rheum; 2008 Dec; 58(12):3753-64. PubMed ID: 19035506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.